Importance of ethnic differences in affecting the outcomes of international trials

被引：2
作者：
Cheng, TO [1 ]
机构：
[1] George Washington Univ, Med Ctr, Washington, DC 20037 USA
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷 / 03期
关键词：
D O I：
10.1053/euhj.2001.3057
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 5 条
  • [1] Cheng TO, 1996, QJM-MON J ASSOC PHYS, V89, P557
  • [2] THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) TRIAL, PHASE-I - A COMPARISON BETWEEN INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR AND INTRAVENOUS STREPTOKINASE - CLINICAL FINDINGS THROUGH HOSPITAL DISCHARGE
    CHESEBRO, JH
    KNATTERUD, G
    ROBERTS, R
    BORER, J
    COHEN, LS
    DALEN, J
    DODGE, HT
    FRANCIS, CK
    HILLIS, D
    LUDBROOK, P
    MARKIS, JE
    MUELLER, H
    PASSAMANI, ER
    POWERS, ER
    RAO, AK
    ROBERTSON, T
    ROSS, A
    RYAN, TJ
    SOBEL, BE
    WILLERSON, J
    WILLIAMS, DO
    ZARET, BL
    BRAUNWALD, E
    [J]. CIRCULATION, 1987, 76 (01) : 142 - 154
  • [3] Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis - Results from InTIME-II
    Giugliano, RP
    Llevadot, J
    Wilcox, RG
    Gurfinkel, EP
    McCabe, CH
    Charlesworth, A
    Thompson, SL
    Antman, EM
    Braunwald, E
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 (18) : 1702 - 1715
  • [4] A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: The TUCC trial
    Ross, AM
    Gao, RL
    Coyne, KS
    Chen, JL
    Yao, KB
    Yang, YJ
    Qin, XW
    Qiao, SB
    Yao, M
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (02) : 244 - 247
  • [5] Why is there so much geographic variation in clinical outcome in international trials of fibrinolytic therapy?
    Van De Werf, F
    [J]. EUROPEAN HEART JOURNAL, 2001, 22 (18) : 1631 - 1632
1